Publications by authors named "Ryosuke Hayami"

Claim this Profile
C
CD44 knockdown and TGF‑β inhibition modulate cell proliferation and invasion in claudin‑low breast cancer cells.
Ryoichi Matsunuma, Kazuo Kinoshita, Sae Imada, Shoko Sato, Ryosuke Hayami

Oncol Rep· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of modified dexamethasone administration sequence on infusion reaction incidence in HER2-positive breast cancer: a randomized multicenter trial.
Ryoichi Matsunuma, Shigeru Nakagaki, Eiji Nakatani, Masayuki Kikuchi, Noriaki Wada, Ryosuke Hayami

Breast Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexities in Adjuvant Endocrine Therapy for Breast Cancer in Female-to-Male Transgender Patients.
Shoko Sato, Sae Imada, Ryosuke Hayami, Kazumori Arai, Rieko Kosugi

Case Rep Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Treatment Resistance in a Patient with Metastatic PD-L1-Positive Breast Cancer and Germline BRCA1 Mutation.
Toko Kumeta, Kei Yamaguchi, Ryosuke Hayami, Kazumori Arai, Michiko Tsuneizumi

Case Rep Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrichment of Immune-Related Genes in Aggressive Primary Breast Angiosarcoma: A Case Report.
Ryoichi Matsunuma, Shoko Sato, Jason Yongsheng Chan, Kazuo Kinoshita, Keisei Taku, Ryosuke Hayami

Case Rep Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term response to olaparib in a patient with metastatic pancreatic cancer associated with hereditary breast and ovarian cancer syndrome.
Michiko Tsuneizumi, Shuzo Terada, Takeshi Usui, Kei Yamaguchi, Ryosuke Hayami

Oxf Med Case Reports· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Modified Immunohistochemical Marker Score and 21-Gene Recurrence Score Assay in Patients with Estrogen Receptor-Positive Breast Cancer.
Kei Yamaguchi, Ryoichi Matsunuma, Ryosuke Hayami, Michiko Tsuneizumi

Oncology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast.
Yuki Usui, Ryoichi Matsunuma, Kei Yamaguchi, Ryosuke Hayami, Aya Muramatsu

Case Rep Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large Breast Tumor Ulceration and Quality of Life in an 80-Year-Old Woman.
Kei Yamaguchi, Ryoichi Matsunuma, Ryosuke Hayami, Michiko Tsuneizumi

Case Rep Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Bowen's Disease of the Nipple and Breast Cancer.
Kei Yamaguchi, Ryoichi Matsunuma, Toko Kumeta, Sae Imada, Ryosuke Hayami

Case Rep Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pneumonia and Acute Kidney Injury Induced by Everolimus Treatment in a Patient with Metastatic Breast Cancer.
Mayuko Nakamura, Ryoichi Matsunuma, Kei Yamaguchi, Ryosuke Hayami, Michiko Tsuneizumi

Case Rep Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility preservation before neoadjuvant chemotherapy in a premenopausal breast cancer patient: a case report.
Arika Kobayashi, Ryoichi Matsunuma, Kei Yamaguchi, Ryosuke Hayami, Michiko Tsuneizumi

Oxf Med Case Reports· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of Estrogen-Receptor-Positive Metastatic Breast Cancer to Olaparib in Late-Line Therapy.
Toko Kumeta, Ryoichi Matsunuma, Kei Yamaguchi, Ryosuke Hayami, Michiko Tsuneizumi

Case Rep Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
Yasuyuki Kojima, Hisanori Kawamoto, Toru Nishikawa, Ryosuke Hayami, Arata Shimo

Clin Breast Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic outcomes and technical considerations of nipple-sparing mastectomies in breast cancer: experience of 425 cases from a single institution.
Ayaka Shimo, Koichiro Tsugawa, Seiko Tsuchiya, Reiko Yoshie, Kyoko Tsuchiya, Ryosuke Hayami

Breast Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Thrombophlebitis in an Elderly Japanese Woman Treated with Tamoxifen for Breast Cancer].
Hiroyuki Takayanagi, Ryosuke Hayami, Michiko Tsuneizumi, Kazuhiko Nakagami

Gan To Kagaku Ryoho· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage.
Takayo Fukuda, Wenwen Wu, Maiko Okada, Ichiro Maeda, Yasuyuki Kojima, Ryosuke Hayami

Cancer Sci· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MED12 exon 2 mutations in phyllodes tumors of the breast.
Satoi Nagasawa, Ichiro Maeda, Takayo Fukuda, Wenwen Wu, Ryosuke Hayami

Cancer Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 ubiquitinates RPB8 in response to DNA damage.
Wenwen Wu, Hiroyuki Nishikawa, Ryosuke Hayami, Ko Sato, Akeri Honda

Cancer Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats.
Makiko Tsuzuki, Wenwen Wu, Hiroyuki Nishikawa, Ryosuke Hayami, Daisuke Oyake

Cancer Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Ryosuke Hayami, Ko Sato, Wenwen Wu, Toru Nishikawa, Junya Hiroi

Cancer Res· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
Ko Sato, Ryosuke Hayami, Wenwen Wu, Toru Nishikawa, Hiroyuki Nishikawa

J Biol Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis